천식 약물유전체 연구에서 시스템 생물학 접근

키워드

참고문헌 (50)

1. Szefler SJ, "Significant variability in response to inhaled corticosteroids for persistent asthma", J Allergy Clin Immunol, 109, pp.410~418 (2002)
2. Malmstrom K, "Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast", Beclomethasone Study Group, 1999, pp.130, 487~495
3. Drazen JM, "Heterogeneity of therapeutic responses in asthma", Br Med Bull, 56, pp.1054~1070 (2000)
4. Szefler SJ, "Characterization of within-subject responses to fluticasone and montelukast in childhood asthma", J Allergy Clin Immunol, 115, pp.233~242 (2005)
5. "Guidance for industry: E15 definitions for genomic biomarkers, pharmacogenomics, pharmacogenetics, genomic data and sample coding categories"[URL]
6. Flaherty KT, "Inhibition of mutated, activated BRAF in metastatic melanoma", N Engl J Med, 363, pp.809~819 (2010)
7. Chen P, "Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan", N Engl J Med, 364, pp.1126~1133 (2011)
8. Corren J, "Lebrikizumab treatment in adults with asthma", N Engl J Med, 365, pp.1088~1098 (2011)
9. "FDA approves updated warfarin (coumadin) prescribing information: new genetic information may help providers improve initial dosing estimates of the anticoagulant for individual patients"[URL]
10. Israel E, "Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial", Lancet, 364, pp.1505~1512 (2004)
11. Giacomini KM, "The pharmacogenetics research network: from SNP discovery to clinical drug response", Clin Pharmacol Ther, 81, pp.328~345 (2007)
12. McCarthy JJ, "The use of single-nucleotide polymorphism maps in pharmacogenomics", Nat Biotechnol, 18, pp.505~508 (2000)
13. Evans WE, "Pharmacogenomics: drug disposition, drug targets, and side effects", N Engl J Med, 348, pp.538~549 (2003)
14. Evans WE, "Pharmacogenomics: translating functional genomics into rational therapeutics", Science, 286, pp.487~491 (1999)
15. Evans WE, "Moving towards individualized medicine with pharmacogenomics", Nature, 429, pp.464~468 (2004)
16. Litonjua AA, "ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts", Am J Respir Crit Care Med, 178, pp.688~694 (2008)
17. Duan QL, "A polymorphism in the thyroid hormone receptor gene is associated with bronchodilator response in asthmatics", Pharmacogenomics J, 13, pp.130~136 (2013)
18. Tantisira KG, "Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids", Hum Mol Genet, 13, pp.1353~1359 (2004)
19. Tantisira KG, "TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids", Proc Natl Acad Sci U S A, 101, pp.18099~18104 (2004)
20. Drazen JM, "Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment", Nat Genet, 22, pp.168~170 (1999)
21. Klotsman M, "Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukast", Pharmacogenet Genomics, 17, pp.189~196 (2007)
22. Himes BE, "Genome-wide association analysis in asthma subjects identifies SPATS2L as a novel bronchodilator response gene", PLoS Genet, 8, pp.e1002824~ (2012)
23. Drake KA, "A genome-wide association study of bronchodilator response in Latinos implicates rare variants", J Allergy Clin Immunol, 133, pp.370~378 (2014)
24. Tantisira KG, "Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma", N Engl J Med, 365, pp.1173~1183 (2011)
25. Tantisira KG, "Genome-wide association identifies the T gene as a novel asthma pharmacogenetic locus", Am J Respir Crit Care Med, 185, pp.1286~1291 (2012)
26. Park HW, "Genetic predictors associated with improvement of asthma symptoms in response to inhaled corticosteroids", J Allergy Clin Immunol, 133, pp.664-9.e5~ (2014)
27. Maitland-van der Zee AH, "Pharmacogenetics of response to statins: where do we stand?", Curr Atheroscler Rep, 7, pp.204~208 (2005)
28. Wilke RA, "Combinatorial pharmacogenetics", Nat Rev Drug Discov, 4, pp.911~918 (2005)
29. Sing CF, "Dynamic relationships between the genome and exposures to environments as causes of common human diseases", World Rev Nutr Diet, 93, pp.77~91 (2004)
30. Moore JH, "The ubiquitous nature of epistasis in determining susceptibility to common human diseases", Hum Hered, 56, pp.73~82 (2003)
31. Thornton-Wells TA, "Genetics, statistics and human disease: analytical retooling for complexity", Trends Genet, 20, pp.640~647 (2004)
32. Quackenbush J, "Extracting meaning from functional genomics experiments", Toxicol Appl Pharmacol, 207(2 Suppl), pp.195~199 (2005)
33. Gajendran VK, "An application of bioinformatics and text mining to the discovery of novel genes related to bone biology", Bone, 40, pp.1378~1388 (2007)
34. Nenadic G, "Terminology-driven mining of biomedical literature", Bioinformatics, 19, pp.938~943 (2003)
35. Yandell MD, "Genomics and natural language processing", Nat Rev Genet, 3, pp.601~610 (2002)
36. Davies SM, "Pharmacogenetics, pharmacogenomics and personalized medicine: are we there yet?", Hematology Am Soc Hematol Educ Program, pp.111~117 (2006)
37. Ritchie MD, "Bioinformatics approaches for detecting gene-gene and gene-environment interactions in studies of human disease", Neurosurg Focus, 19, pp.E2~ (2005)
38. Moore JH, "STUDENTJAMA. The challenges of whole-genome approaches to common diseases", JAMA, 291, pp.1642~1643 (2004)
39. Aderem A, "Systems biology: its practice and challenges", Cell, 121, pp.511~513 (2005)
40. Koster ES, "Systems biology in pharmacogenomic research: the way to personalized prescribing?", Pharmacogenomics, 10, pp.971~981 (2009)
41. Kirschner MW, "The meaning of systems biology", Cell, 121, pp.503~504 (2005)
42. Morel NM, "Primer on medical genomics. Part XIV: Introduction to systems biology: a new approach to understanding disease and treatment", Mayo Clin Proc, 79, pp.651~658 (2004)
43. Dahlin A, "Integrative systems biology approaches in asthma pharmacogenomics", Pharmacogenomics, 13, pp.1387~1404 (2012)
44. Needham CJ, "A primer on learning in Bayesian networks for computational biology", PLoS Comput Biol, 3, pp.e129~ (2007)
45. Friedman N, "Using Bayesian networks to analyze expression data", J Comput Biol, 7, pp.601~620 (2000)
46. Beerenwinkel N, "Probability, statistics, and computational science", Methods Mol Biol, 855, pp.77~110 (2012)
47. Himes BE, "Predicting response to short-acting bronchodilator medication using Bayesian networks", Pharmacogenomics, 10, pp.1393~1412 (2009)
48. Franke L, "eQTL analysis in humans", Methods Mol Biol, 573, pp.311~328 (2009)
49. Grundberg E, "Global analysis of the impact of environmental perturbation on cis-regulation of gene expression", PLoS Genet, 7, pp.e1001279~ (2011)
50. Qiu W, "Pharmacogenomics: novel loci identification via integrating gene differential analysis and eQTL analysis", Hum Mol Genet, 23, pp.5017~5024 (2014)

관련 논문AI추천